AMAG Pharmaceuticals

AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company with a focus on maternal health, anemia and cancer supportive care. The primary goal of AMAG and its maternal health division, Lumara Health, is to bring to market therapies that provide clear benefits and improve patients' lives. In addition to continuing to pursue opportunities to make new advancements in patients' health and to enhance treatment accessibility, AMAG intends to continue to expand and diversify its portfolio through the in-license or purchase of additional pharmaceutical products or companies.
Type
Public
HQ
Waltham, US
Founded
1981
Size (employees)
545 (est)-1%
AMAG Pharmaceuticals was founded in 1981 and is headquartered in Waltham, US

AMAG Pharmaceuticals Office Locations

AMAG Pharmaceuticals has office in Waltham
Waltham, US

AMAG Pharmaceuticals Metrics

AMAG Pharmaceuticals Summary

Market capitalization

$734.9 m

Closing share price

$22.7
AMAG Pharmaceuticals's current market capitalization is $734.9 m.

AMAG Pharmaceuticals Financials

AMAG Pharmaceuticals's revenue is $80.9 m in FY, 2013 which is a 35% decrease from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$80.9 m$124.4 m$418.3 m$532.1 m

Revenue growth, %

53.8%236.3%27.2%

Cost of goods sold

$12 m$20.3 m$10 m$20.6 m

Gross profit

$68.9 m$104.1 m$408.3 m

Operating expense total

$80.5 m$107.9 m$297.1 m$453.2 m

EBIT

($7.6 m)($3.8 m)$111.2 m$78.9 m

Interest expense

($14.7 m)($53.3 m)($73.2 m)

Interest income

$3.1 m

Income tax expense

$153.2 m$7.1 m$11.5 m

Pre tax profit

($9.6 m)$9.1 m

Net Income

($9.6 m)$135.8 m$32.8 m($2.5 m)

Operating cash flow

($19.3 m)$92.3 m$109.4 m

AMAG Pharmaceuticals Market Value History

AMAG Pharmaceuticals Company Life

You may also be interested in